Sacubitril/Valsartan in Heart Failure with Hypertension Patients: Real-World Experiences on Different Ages, Drug Doses, and Renal Functions
ConclusionsSac/val could reduce BP and improve cardiac structural and functional parameters in hypertensive patients with HF, even with less than target doses. However, more attention should be paid to older patients and renal dysfunction patients when using sac/val because of additional risks in adverse events.
Source: High Blood Pressure and Cardiovascular Prevention - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | China Health | Diovan | Electronic Medical Records (EMR) | Heart | Heart Failure | Hypertension | Japan Health | Study